ABG-WTT Global Life Science Capital Partners GP
CENTRAL, HONG KONG, K3files as ABG-WTT Global Life Science Capital Partners GP Ltd
$9m in 2 US stocks at the end of 30 June 2026. The top 10 are 100.0% of the money. It changed about 3.3% of the portfolio this quarter.
Value
$9m
Stocks
2
Top 10 share
100.0%
Turnover
3.3%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
- CeribellCBLL62.6% of the fund-38%
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| CeribellCBLL | 62.6% | $5m | 275,328 | -38% |
| Rapid Micro BiosystemsRPID | 37.4% | $3m | 1,848,296 | Held |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is down 68.0% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.